Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Michael John Peck, Edward B. Sanders, Gerhard Scherer, Frank Lüdicke & Rolf Weitkunat. (2018) Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products. Biomarkers 23:3, pages 213-244.
Read now
Read now
Articles from other publishers (30)
Andi Flory & Heather Wilson-Robles. (2024) Noninvasive Blood-Based Cancer Detection in Veterinary Medicine. Veterinary Clinics of North America: Small Animal Practice 54:3, pages 541-558.
Crossref
Crossref
Huub H. van Rossum & Stefan Holdenrieder. (2024) Lung cancer tumor marker analysis: A clinical laboratory perspective. Tumor Biology 46:s1, pages S9-S14.
Crossref
Crossref
Inga Trulson, Frank Klawonn, Joachim von Pawel & Stefan Holdenrieder. (2024) Improvement of differential diagnosis of lung cancer by use of multiple protein tumor marker combinations. Tumor Biology 46:s1, pages S81-S98.
Crossref
Crossref
Kimberly Geiger, Markus Joerger, Max Roessler, Karina Hettwer, Christoph Ritter, Kirsten Simon, Steffen Uhlig & Stefan Holdenrieder. (2024) Missing prognostic value of soluble PD-1, PD-L1 and PD-L2 in lung cancer patients undergoing chemotherapy – A CEPAC-TDM biomarker substudy. Tumor Biology 46:s1, pages S355-S367.
Crossref
Crossref
Kimberly Geiger, Markus Joerger, Max Roessler, Karina Hettwer, Christoph Ritter, Kirsten Simon, Steffen Uhlig & Stefan Holdenrieder. (2024) Relevance of tumor markers for prognosis and predicting therapy response in non-small cell lung cancer patients: A CEPAC-TDM biomarker substudy. Tumor Biology 46:s1, pages S191-S206.
Crossref
Crossref
Alexander Rupp, Sophie Bahlmann, Nicolai Trimpop, Joachim von Pawel & Stefan Holdenrieder. (2024) Lack of clinical utility of serum macrophage migration inhibitory factor (MIF) for monitoring therapy response and estimating prognosis in advanced lung cancer. Tumor Biology 46:s1, pages S341-S353.
Crossref
Crossref
Tasha Barr, Shoubao Ma, Zhixin Li & Jianhua Yu. (2024) Recent advances and remaining challenges in lung cancer therapy. Chinese Medical Journal 137:5, pages 533-546.
Crossref
Crossref
Sylvia A.A.M. Genet, Esther Visser, Maggy Youssef-El Soud, Huub N.A. Belderbos, Gerben Stege, Marleen E.A. de Saegher, Susan C. van 't Westeinde, Luc Brunsveld, Maarten A.C. Broeren, Daan van de Kerkhof, Federica Eduati, Ben E.E.M. van den Borne & Volkher Scharnhorst. (2024) Strengths and challenges in current lung cancer care: Timeliness and diagnostic procedures in six Dutch hospitals. Lung Cancer 189, pages 107477.
Crossref
Crossref
Francis Williams Ojara, Andrea Henrich, Nicolas Frances, Yomna M. Nassar, Wilhelm Huisinga, Niklas Hartung, Kimberly Geiger, Stefan Holdenrieder, Markus Joerger & Charlotte Kloft. (2023) A prognostic baseline blood biomarker and tumor growth kinetics integrated model in paclitaxel/platinum treated advanced non‐small cell lung cancer patients. CPT: Pharmacometrics & Systems Pharmacology 12:11, pages 1714-1725.
Crossref
Crossref
Meng Zhang, Yi Feng, Changda Qu, Meizhu Meng, Wenmei Li, Meiying Ye, Sisi Li, Shaolei Li, Yuanyuan Ma, Nan Wu & Shuqin Jia. (2022) Comparison of the somatic mutations between circulating tumor DNA and tissue DNA in Chinese patients with non-small cell lung cancer. The International Journal of Biological Markers 37:4, pages 386-394.
Crossref
Crossref
A. D. Tahanovich, N. N. Kauhanka, D. I. Murashka, A. V. Kolb, V. I. Prokhorova, O. V. Got’ko & L. A. Derzhavets. (2022) Preoperative blood markers for prediction of recurrence-free survival after surgical treatment of patients with stage III lung
adenocarcinoma. Russian Clinical Laboratory Diagnostics 67:11, pages 640-646.
Crossref
Crossref
Fengchang Yang, Jiayi Zhang, Liu Zhou, Wei Xia, Rui Zhang, Haifeng Wei, Jinxue Feng, Xingyu Zhao, Junming Jian, Xin Gao & Shuanghu Yuan. (2021) CT-based radiomics signatures can predict the tumor response of non-small cell lung cancer patients treated with first-line chemotherapy and targeted therapy. European Radiology 32:3, pages 1538-1547.
Crossref
Crossref
Yiming Jin, Megan A. Schladetsch, Xueting Huang, Marcy J. Balunas & Andrew J. Wiemer. (2022) Stepping forward in antibody-drug conjugate development. Pharmacology & Therapeutics 229, pages 107917.
Crossref
Crossref
A. D. Tahanovich, N. N. Kauhanka, V. I. Prokhorova, L. A. Derzhavets, A. V. Kolb & D. I. Murashkа. (2021) Diagnostic models of non-small cell lung cancer based on determination of blood cytokines and their receptors. Proceedings of the National Academy of Sciences of Belarus, Medical series 18:4, pages 445-455.
Crossref
Crossref
Sarah Panahabadi, Katrin Heindel, Andreas Mueller, Stefan Holdenrieder & Florian Kipfmueller. (2021) Increased circulating cytokeratin 19 fragment levels in preterm neonates receiving mechanical ventilation are associated with poor outcome. American Journal of Physiology-Lung Cellular and Molecular Physiology 321:6, pages L1036-L1043.
Crossref
Crossref
Nandor Barany, Anita Rozsas, Zsolt Megyesfalvi, Michael Grusch, Balazs Hegedus, Christian Lang, Kristiina Boettiger, Anna Schwendenwein, Anna Tisza, Ferenc Renyi-Vamos, Karin Schelch, Konrad Hoetzenecker, Mir Alireza Hoda, Sandor Paku, Viktoria Laszlo & Balazs Dome. (2021) Clinical relevance of circulating activin A and follistatin in small cell lung cancer. Lung Cancer 161, pages 128-135.
Crossref
Crossref
Mirte Muller, Roland Hoogendoorn, Ruben J.G. Moritz, Vincent van der Noort, Mirthe Lanfermeijer, Catharina M. Korse, Daan van den Broek, Jelle J. ten Hoeve, Paul Baas, Huub H. van Rossum & Michel M. van den Heuvel. (2021) Validation of a clinical blood-based decision aid to guide immunotherapy treatment in patients with non-small cell lung cancer. Tumor Biology 43:1, pages 115-127.
Crossref
Crossref
Yu Chen, Emory Zitello, Rui Guo & Youping Deng. (2021) The function of LncRNAs and their role in the prediction, diagnosis, and prognosis of lung cancer. Clinical and Translational Medicine 11:4.
Crossref
Crossref
Chong Chen, Xiaoling Tian, Xiaopeng Zhao & Li Ren. (2020) Clinical study of serum IGFBP7 in predicting lymphatic metastasis in patients with lung adenocarcinoma. Current Problems in Cancer 44:6, pages 100584.
Crossref
Crossref
P.-F. Hou, L.-J. Zhu, Y. Pan, X.-C. Sun & J. Pu. (2020) The relationship between regulatory T cells and radiation therapy. Cancer/Radiothérapie 24:1, pages 81-84.
Crossref
Crossref
Tiago M. Alfaro & Carlos Robalo Cordeiro. (2020) Comorbidity in idiopathic pulmonary fibrosis - what can biomarkers tell us?. Therapeutic Advances in Respiratory Disease 14, pages 175346662091009.
Crossref
Crossref
M. G. Dal Bello, R. A. Filiberti, A. Alama, A. M. Orengo, M. Mussap, S. Coco, I. Vanni, S. Boccardo, E. Rijavec, C. Genova, F. Biello, G. Barletta, G. Rossi, M. Tagliamento, C. Maggioni & F. Grossi. (2019) The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients. Journal of Translational Medicine 17:1.
Crossref
Crossref
Santoni-Rugiu, Melchior, Urbanska, Jakobsen, Stricker, Grauslund & Sørensen. (2019) Intrinsic resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance. Cancers 11:7, pages 923.
Crossref
Crossref
R. Moritz, M. Muller, C.M. Korse, D. van den Broek, P. Baas, V. van den Noort, J.J. ten Hoeve, M.M. van den Heuvel & H.H. van Rossum. (2018) Diagnostic validation and interpretation of longitudinal circulating biomarkers using a biomarker response characteristic plot. Clinica Chimica Acta 487, pages 6-14.
Crossref
Crossref
Anna Maria Wirsing, Ida Korsnes Ervik, Marit Seppola, Lars Uhlin-Hansen, Sonja Eriksson Steigen & Elin Hadler-Olsen. (2018) Presence of high-endothelial venules correlates with a favorable immune microenvironment in oral squamous cell carcinoma. Modern Pathology 31:6, pages 910-922.
Crossref
Crossref
Jun Lu, Hongtao Wang, Xueli Zhang & Xuemei Yu. (2018) HbA1c is Positively Associated with Serum Carcinoembryonic Antigen (CEA) in Patients with Diabetes: A Cross-Sectional Study. Diabetes Therapy 9:1, pages 209-217.
Crossref
Crossref
Michael J. Duffy & Ken O’Byrne. 2018.
1
21
.
Luca Giovanella, Federica D’Aurizio & Renato Tozzoli. 2018. Atlas of Thyroid and Neuroendocrine Tumor Markers. Atlas of Thyroid and Neuroendocrine Tumor Markers
175
189
.
Niklas K. Finnberg, Prashanth Gokare, Avital Lev, Sergei I. Grivennikov, Alexander W. MacFarlaneIVIV, Kerry S. Campbell, Ryan M. Winters, Karen Kaputa, Jeffrey M. Farma, Abbas El-Sayed Abbas, Luigi Grasso, Nicholas C. Nicolaides & Wafik S. El-Deiry. (2017) Application of 3D tumoroid systems to define immune and cytotoxic therapeutic responses based on tumoroid and tissue slice culture molecular signatures. Oncotarget 8:40, pages 66747-66757.
Crossref
Crossref
L. Giovanella, M. Imperiali & P. Trimboli. (2017) Role of serum cytokeratin 19 fragment (Cyfra 21.1) as a prognostic biomarker in patients with differentiated thyroid cancer. Scientific Reports 7:1.
Crossref
Crossref